This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: F.i.s. Fabbrica Italiana Sintetici S.p.a.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Floriana Semeraro: Innovator in Pharmaceutical Synthesis
Introduction
Floriana Semeraro is a notable inventor based in Montecchio Maggiore, Italy. She has made significant contributions to the field of pharmaceutical synthesis, particularly in the development of processes that enhance the efficiency of drug production. Her work is characterized by a focus on innovative methodologies that streamline complex chemical processes.
Latest Patents
Floriana holds a patent for a process aimed at the preparation of key intermediates for the synthesis of Eltrombopag or its salts. The patent, titled "Process for the preparation of key intermediates for the synthesis of Eltrombopag or salt thereof," describes an improved method that utilizes the intermediate 5′-Chloro-2′-hydroxy[1,1′-biphenyl]-3-carboxylic acid alkaline metal salt. This advancement is crucial for the pharmaceutical industry, as it enhances the production of important therapeutic agents.
Career Highlights
Floriana is currently employed at F.i.s. Fabbrica Italiana Sintetici S.p.a., where she continues to innovate in the field of chemical synthesis. Her expertise and dedication have positioned her as a key player in her organization, contributing to the development of new pharmaceutical products.
Collaborations
Floriana collaborates with her coworker, Paolo Stabile, to further enhance their research and development efforts. Their partnership exemplifies the importance of teamwork in driving innovation within the pharmaceutical sector.
Conclusion
Floriana Semeraro's contributions to pharmaceutical synthesis through her innovative patent demonstrate her commitment to advancing the field. Her work not only benefits her company but also has the potential to impact the broader pharmaceutical industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
